Advertisement

Topics

InDex Pharmaceuticals AB Receives Orphan-Drug Designation For Pediatric Ulcerative Colitis In The U.S.

20:00 EDT 8 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: InDex Pharmaceuticals AB Receives Orphan-Drug Designation For Pediatric Ulcerative Colitis In The U.S.

NEXT ARTICLE

More From BioPortfolio on "InDex Pharmaceuticals AB Receives Orphan-Drug Designation For Pediatric Ulcerative Colitis In The U.S."

Quick Search
Advertisement